Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
From CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
October 31, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Friday
September 27, 2024
From CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
From CNBC.com News
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
From CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
July 22, 2024
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
June 24, 2024
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
From CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
April 29, 2024
From CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
April 25, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
From CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.